In his latest research note, analyst Richard Vosser confirms his recommendation. The broker JP Morgan is keeping its Neutral rating. The target price is unchanged at EUR 60. | May 11, 2023
EARNINGS/SALES RELEASESBayer was abruptly evicted from the agro Shangri La and the pharma business was a mixed and more costly bag. This led to some differences with the consensus . These things. | May 11, 2023
Gunther Zechmann from Bernstein retains his positive opinion on the stock with a Buy rating. The target price has been modified and is now set at EUR 90 compared to EUR 92. | May 9, 2023
In a research note published by Sebastian Bray, Berenberg advises its customers to buy the stock. The target price is unchanged at EUR 70. | May 5, 2023
The European Union
should put mechanisms in place to allow drugmakers to charge
higher prices in wealthy European countries and lower prices in
poorer nations to assure more equitable patient access. | May 5, 2023